KLRK1 and type 1 diabetes mellitus: Strangely, this is in contradiction to previous observations in which NCR1 (NKp46) deficient mice were observed to have reduced T1D development (43), and where treatment of NOD mice with anti-NKG2D antibody prior to disease onset halted progression altogether (66, 67).